Sadhana Nitrochem: No Deviation in Rights Issue Fund Utilization for Q1 FY27
Sadhana Nitrochem Limited reported no deviation in the utilization of ₹263.53 Crores raised via Rights Issue on March 12, 2026. Funds were utilized across Inter-Corporate Deposit, Promoters Loan, Term Loan, Working Capital, General Corporate Purposes, and Issue Expenses for the quarter ended June 30, 2026.
This is a routine compliance disclosure confirming adherence to the original plan for fund utilization. It does not introduce any new information that would significantly impact the company's stock or operations.
The announcement is a routine compliance filing confirming no deviation in fund utilization, which is neutral in nature. It does not provide new positive or negative information.
Sadhana Nitrochem Limited has confirmed that there is no deviation or variation in the utilization of proceeds raised through its Rights Issue. The company submitted a statement to BSE Limited and the National Stock Exchange of India Limited, as required by Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The funds, amounting to ₹263.53 Crores, were raised on March 12, 2026. The report covers the quarter ended June 30, 2026.
The statement, reviewed by the Audit Committee, indicates that the allocated funds were utilized as follows: Inter-Corporate Deposit (₹131.98 Crores), Promoters Loan (₹81.00 Crores), Term Loan (₹6.18 Crores), Long-Term Working Capital (₹16.09 Crores), General Corporate Purposes (₹27.00 Crores), and Issue Related Expenses (₹1.28 Crores). All amounts were utilized in line with the original allocation, with no deviation or variation reported. The monitoring agency for these funds is Acuite Ratings and Research Limited.
What to do with a filing like this
Sadhana Nitrochem Limited filed this with the NSE as a statutory disclosure, categorised under debt fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sadhana Nitrochem Limited. Read the original for the full detail.